Bharat Biotech submits Phase 3 data for Covaxin
Bharat Biotech is scaling scale up of manufacturing capacity and adding production lines across multiple facilities in Hyderabad and Bengaluru to make 700 million doses of Covaxin annually. Bharat Biotech has submitted Phase 3 trial data for Covaxin to the Drug Controller General (DGCI) of India over the weekend. VK Paul, member, health, Niti Aayog, … Read more